These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1946358)
1. Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Hart MK; Weinhold KJ; Scearce RM; Washburn EM; Clark CA; Palker TJ; Haynes BF Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9448-52. PubMed ID: 1946358 [TBL] [Abstract][Full Text] [Related]
2. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice. Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787 [TBL] [Abstract][Full Text] [Related]
3. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Sastry KJ; Nehete PN; Venkatnarayanan S; Morkowski J; Platsoucas CD; Arlinghaus RB Virology; 1992 Jun; 188(2):502-9. PubMed ID: 1316670 [TBL] [Abstract][Full Text] [Related]
4. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120. Nehete PN; Casement KS; Arlinghaus RB; Sastry KJ Cell Immunol; 1995 Feb; 160(2):217-23. PubMed ID: 7720083 [TBL] [Abstract][Full Text] [Related]
5. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700 [TBL] [Abstract][Full Text] [Related]
6. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. Johnson RP; Trocha A; Buchanan TM; Walker BD J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review. Becker Y Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271 [TBL] [Abstract][Full Text] [Related]
8. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. Layton GT; Harris SJ; Gearing AJ; Hill-Perkins M; Cole JS; Griffiths JC; Burns NR; Kingsman AJ; Adams SE J Immunol; 1993 Jul; 151(2):1097-107. PubMed ID: 8335892 [TBL] [Abstract][Full Text] [Related]
9. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Doe B; Steimer KS; Walker CM Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139 [TBL] [Abstract][Full Text] [Related]
10. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response. Nehete PN; Arlinghaus RB; Sastry KJ Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033 [TBL] [Abstract][Full Text] [Related]
11. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862 [TBL] [Abstract][Full Text] [Related]
12. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses. Wagner R; Böltz T; Deml L; Modrow S; Wolf H J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647 [TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. Hart MK; Palker TJ; Matthews TJ; Langlois AJ; Lerche NW; Martin ME; Scearce RM; McDanal C; Bolognesi DP; Haynes BF J Immunol; 1990 Oct; 145(8):2677-85. PubMed ID: 1698859 [TBL] [Abstract][Full Text] [Related]
14. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. Nardelli B; Tam JP Immunology; 1993 Jul; 79(3):355-61. PubMed ID: 8104882 [TBL] [Abstract][Full Text] [Related]
15. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo. Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1. Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219 [TBL] [Abstract][Full Text] [Related]
17. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes. Alexander MA; Damico CA; Wieties KM; Hansen TH; Connolly JM J Exp Med; 1991 Apr; 173(4):849-58. PubMed ID: 1901079 [TBL] [Abstract][Full Text] [Related]
18. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. Shirai M; Pendleton CD; Berzofsky JA J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784 [TBL] [Abstract][Full Text] [Related]
19. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. Johnson RP; Trocha A; Buchanan TM; Walker BD J Virol; 1993 Jan; 67(1):438-45. PubMed ID: 7677956 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector. Carbonetti NH; Tuskan RG; Lewis GK AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]